Dr. Mellinghoff is Chair of the Department of Neurology and incumbent of the Evnin Family Chair in Neuro-Oncology at Memorial Sloan Kettering Cancer Center. Dr. Mellinghoff contributed new insights into deregulated signaling pathway in CNS cancer and helped develop approaches to evaluate and therapeutically target these pathways in the clinic.